ArticleLung2025

Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection.

Chiara Lanfranchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.